Skip to content

Exelixis EXEL Financing Cash Flow

Financing Cash Flow at other companies

Eli Lilly logo
Eli LillyLLY
-$3.47B-351%
Pfizer logo
PfizerPFE
-$2.86B+45.4%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$3.8M-50.5%
Incyte logo
IncyteINCY
$84.82M+769%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$57.26M+2,504%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$549.89M+812%

Other financials

Income statement

See full
Revenue$610.8M+10.0%
Gross profit$590.9M+10.2%
Operating income$251.3M+34.5%
Net income$210.5M+31.9%
EPS (diluted)$0.79+43.6%

Balance sheet

See full
Cash & equivalents$226.2M+23.1%
Total debt$169.5M-9.4%
Total equity$1.9B-9.2%
Total assets$2.6B-8.6%

Cash flow

See full
Operating cash flow$251.8M+19.1%
CapEx$1.5M-48.9%
Free cash flow$250.3M+20.1%

Valuation

See full
Market cap$13.05B+10.1%
Enterprise value$12.99B+9.5%
P/E15.7×-2.8×
P/S5.5×+0.3×

Profitability

See full
Gross margin96.4%-0.3pp
Operating margin39.4%+6.3pp
Net margin35.1%+7.1pp
FCF margin38.6%+2.9pp

Returns & leverage

See full
Return on equity41%+10.8pp
Debt / equity0.1×0.0×
Current ratio3.3×-0.2×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exelixis's financing cash flow?
Exelixis (EXEL) reported financing cash flow of -$457.11M in Q1 2026.
How has Exelixis's financing cash flow changed year-over-year?
Exelixis's financing cash flow decreased by 55.0% year-over-year, from -$294.82M to -$457.11M.
What is the long-term trend for Exelixis's financing cash flow?
Over 3 years (2021 to 2025), Exelixis's financing cash flow has grown at a 303.1% compound annual growth rate (CAGR), from -$14.8M to -$969.59M.
What does financing cash flow mean?
The net cash flow from activities involving shareholders and lenders.
How do you interpret financing cash flow?
Negative values often indicate that the company is returning capital to shareholders or paying down debt, while positive values suggest the company is raising capital through debt or equity issuance.
How does financing cash flow compare across companies?
Highly dependent on corporate strategy; peers may show negative values when prioritizing buybacks or positive values when funding large acquisitions.